Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment.

Autor: McClendon, McKee J.1, Hernandez, Santiago2, Smyth, Kathleen A.1,3,4, Lerner, Alan J.1,4,5 alan.lerner@case.edu
Zdroj: Journal of Alzheimer's Disease. 2009, Vol. 16 Issue 3, p577-583. 7p. 1 Diagram, 2 Charts.
Databáze: Academic Search Ultimate